Oncology

Novartis booth at AACR 2026
Biotech

Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?

It’s been over four years since Novartis shook up the CAR-T space with its T-Charge platform. But that’s a lifetime in the world of cell therapies.
James Waldron May 22, 2026 8:28am
IPO initial public offering

Parabilis, fresh from inking Regeneron pact, plans IPO

May 20, 2026 5:25am
Close up of male doctor holding clipboard while talking to patients waiting in line at medical clinic

Clinical trial flaws ‘being scaled, not solved’ by AI: report

May 19, 2026 10:48am
Model Medicines

Model Meds aims to ‘discover new colors’ in drug discovery quest

May 15, 2026 9:45am
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed

May 12, 2026 1:56am
pipeline pipes RD research

BeOne shelves 5 cancer programs, halts ph. 2 arthritis trial

May 7, 2026 11:15am
More News

Amgen abandons cancer, Sjögren’s drugs over weak ph.2 data

May 1, 2026 1:45am

BeOne signs $2B deal for option on preclinical trispecific

Apr 30, 2026 7:55am

Why the next blockbuster in GSK CEO's sights could be in cancer

Apr 29, 2026 7:16am

Compass Therapeutics' stock heads south after bispecific OS miss

Apr 27, 2026 10:55am